MELBOURNE, Australia, Aug. 28, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for…Original Article
Telix Submits NDA for TLX101-CDx (Pixclara) Brain Cancer Imaging Agent
